Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Totally 12,292,551 shares dumped at 0.0002 as of today! Who did? Why? Anyway the TA is no longer available for SAFC!
Me too. Total 12,259,301 shares dumped at 0.0002 as of today! Hopefully SAFC can still trade on the OTC Pink Sheet market, instead of on the OTC Grey Sheet market as its sister stock MFTH did now...
http://www.otcmarkets.com/stock/SAFC/quote
http://www.otcmarkets.com/stock/MFTH/quote
To completely remove the current "SEC Reporting - Delinquent" issue, SAFC needs to file a Form 15-12G or Form 15-15D like the following non-reporting peer did:
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=8963654
Just my Humble Opinion:
At this juncture I believe it is safe to say that
> SAFC has no plans on pursuing the voice activated application.
> Regardles of the patent value it is worthless if NOT executed.
> The only hope is if a real company uses this as a shell.
> At this point it is a hit or miss.
> No news for 3 years = SAFC is well DEAD
>>>> I hope I am wrong <<<<
Regardless of the final outcome.........
> I will never ever buy shares of a company located outside of the USA!!
> I am GUILTY of being a BAGHOLDER!!!!!!
If I knew safc,the company not the stock,had even miniscule amount of a pulse I would be scooping up shares down here but I have no f@king idea they even exist that's what blows. Been stuck holder in other tickers before but at least I knew there was some one behind the scenes running their company into the ground the scumbags they were lol
So Cellar Boxing is next............
LOL Just what I wanted to hear
I got some of those gifts.
Total 11,459,401 shares dumped at 0.0002 as of today! We might see 0.0001 x 0.0002 as soon as tomorrow since only 20K shares bid at 0.0002 now...
Thousands of non-reporting OTC stocks are just like SAFC: no any filing nor any updating for many years or even for decades! But they all are trading normally and bouncing every certain amount of time. As a shareholder I'm happy with the current SAFC status ("STOP" sign Pink Sheet tier) unless something happens like the SEC/FINRA did to its sister stock MFTH (Grey Sheet tier now)! Anyway if a shareholder is not happy with SAFC then one could either liquidate all the shares at the bid while SAFC still has the bid or push the company management to bring SAFC back to the "Current" status or at least file a Form 15-12G...
Nothing to be wowed about nothing to be surprised about either. We have what has turned out to be turd of ticker for some time now and someone{s} has come to that conclusion also. Cant say I blame them. Silence for over 3 years will have that type of effect.
Wow, total 10,459,401 shares dumped at 0.0002 as of today! Another 1M shares added to that number today.
Thanks for the info.
That 1.5M shares of 0.0002s seller must kick himself/herself now since the bid is up 50% at 0.0003 now!
I'm hanging on to mine.
It is hard to believe someone just sold 1,500,000 shares at the All-Time Low 0.0002 today! Why? Some SAFC shareholder is so impatient!
Yes. 5.42M-0.0002 x 2.51M-0.0003 now. The next ask is 999K-0.0006! Only 113M shares FIXED Tiny float in which just about 30M shares float available for trading! Measly 38M shares Maximal Trading Volume in history...
http://ih.advfn.com/videos/stock-research/safecode-drug-technologies-corp-safc_0ROs06_2ZPM
Even a "Caveat Emptor" non-reporting stock could hit $1,301,396.81 Market Value with 929,569,148 shares Large OS! To match the Same MV with that peer, SAFC will hit the New high 0.0060 which is 20 Times of the current price 0.0003!
4.42M-0.0002 x 250K-0.0004 now. SAFC should test 0.0004 ask today...
That would be nice
SAFC is still trading at mere $65K MV now v.s. that peer ever hit $308K MV today... To match the Same Market Value --- $309,230.4, SAFC should hit 0.00141 which is the current 52-week high!
It seems the dirt cheap 0.0003s are completely dried out today! 0.0004 will be the lowest price to get in before SAFC tests 0.0007 again...
SAFC (113M/219M shares float/OS) is Hyper Undervalued now! With much higher SS (328M/343M shares float/OS) the non-reporting peer already hit the New 52-week high 0.0009 today v.s. SAFC at measly 0.0003 now!
Look at that 4 share trade, I hope they are talking about gulfing.....4LOOK-OUT
SAFC is trading at Huge Discount price 0.0003 now v.s. it ever hit 0.0195 with the Same FIXED Tiny SS! Hyper Undervalued --- measly less than $66K MV now! The record high is 65 Times of the current ridiculous low price!
http://ih.advfn.com/videos/stock-research/safecode-drug-technologies-corp-safc_0ROs06_2ZPM
5.42M-2 x 1.6M-4 now. SAFC: The next ask is 244K-0.0005 from Real-Time Level2!
Nice Slapping action! Those 0.0003s are completely gone now! 0.0004 is the current ask!
I just put in a buy to take out those 3's
4.92M x 0.75M now. It is possible for some fractional hidden shares with that 10K ask at 0.0004... But the size of hiiden shares should be very small based on the past experience here!
What? SAFC is not a diluting stock and its SS has been FIXED since 2013!
I see CSTI and CDEL sitting at .0004 with 10K each, I do not trust that. They could have a stack between them.
0.0003s are dirt cheap since it is almost impossible to steal any 0.0002s... SAFC has only about 30M shares FIXED Tiny float available for trading!
Thinking about taking out those 3's
Agreed. 4.4M-0.0002 x 0.74M-0.0003 now. The next ask is 20K-0.0004, then 244K-0.0005. SAFC just hit 0.0005 last Thursday...
With the Same FIXED Tiny SS it ever hit the Record High 0.0195 which is 65 Times of the current joke low price 0.0003!
http://ih.advfn.com/videos/stock-research/safecode-drug-technologies-corp-safc_0ROs06_2ZPM
I'm still watching
SAFC just started another wave of bounce last week! Once the dirt cheap 0.0004s are taken out the most recent high 0.0007 should be quickly tested again... 0.0004 is also the 200-Day MAL which is the last technical resistance!
http://ih.advfn.com/videos/stock-research/safecode-drug-technologies-corp-safc_0ROs06_2ZPM
5.409M-0.0002 x 490K-0.0003 now. The next ask is 250K-0.0004.
SAFC will start a New bounce as soon as tomorrow since some weak hands had liquidated their positions today... Hyper Oversold now!
850K-0.0003 x 250K-0.0004 now. Nice bid support! Measly $100 worthy slapping action will take out all the dirt cheap 0.0004s...
0.0005 just hit! 5.66M-0.0002 x 250K-0.0004 now. Very Thin asks from the Level2! Easy to break out the 52-week high 0.0014 with nice slapping volumes (say 15M shares)...
http://ih.advfn.com/videos/stock-research/safecode-drug-technologies-corp-safc_0ROs06_2ZPM
SAFC is up 66.67% so far with large Slapping volumes! On fire today...
4.17M-0.0002 x 282K-0.0003 now. Who are selling SAFC at such low? Why? Anyway those shares worth measly $84.6!
I meant he/she should have sold those shares at 33.33% Higher bid 0.0004 yesterday if that were not a manipulation sale! Why would anyone want to sell the shares at the lower price 0.0003 while one could sell at the higher price 0.0004? Yes, very strong bids support indeed!
I know right .. I guess somebody needed toll money .. I see feecq bid is building up nicely
Followers
|
82
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
12651
|
Created
|
11/07/12
|
Type
|
Free
|
Moderators |
(3) Marketable Securities
On November 26, 2012, the Company entered into a share exchange agreement with Biomedix Incubator, an Israeli company and a shareholder of Gefen Biomed Investments, a publicly traded Israeli company. The Company issued 1,082,851 shares to Biomedix Incubator and received in return 921,790* shares of Gefen Biomed Investments. The shares were valued at $194,913 which was the market price of the Company’s shares on the date of the exchange. The investment in Gefen is less than 4.9% of Gefen’s outstanding stock.
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=9453715
327
* Gefen BioMed Investments currently trades @ 15.20 ILS or $3.87 USD per share which makes the total value of this investment $3,567,327 USD
http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=GEFEN:IT
JERUSALEM, November 1, 2012 /PRNewswire/ --
SafeCode Drug Technologies Corp. (OTCBB: SAFC), a developer of patent-pending voice recognition technology that reduces the risks of errors during the administration of prescription medications, announced today that shares of SafeCode Drug Technologies common stock have commenced trading on the OTC Bulletin Board under the symbol "SAFC".
Trading began shortly after the company was granted eligibility status by the Depository Trust Company (DTC).
SafeCode is the developer of the world's first patent-pending voice recognition technology used to confirm prescription medications prior to their administration at home or in a medical center.
Using SafeCode technology, prescription medications stored in specially designed locked containers can only be accessed and administered once the caregiver or patient correctly announces the name of the drug.
The technology ensures that the appropriate medication is being administered, as mistakes have accounted for thousands of deaths in recent years. Often, nurses, doctors or patients are not careful when giving or taking medications, and many medication's packaging may look similar. SafeCode Technology prevents medication errors, and thereby reduces the risk of severe injury or accidental death.
"We are certain that the wider investment community will recognize the commercial potential for SafeCode Drug Technologies," said Joel Klopfer , Chief Executive Officer of SafeCode Drug Technologies. "We are excited to bring this potentially life-saving technology to market, and will keep our investors abreast of the company's development in the coming weeks and months."
About SafeCode Drug Technologies
SafeCode Drug Technologies is the developer of a patent-pending voice recognition technology that provides an essential degree of security that can effectively prevent unauthorized administration of a prescription medication.
Forward-Looking Statements
This letter contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities Exchange Act of 1934 as amended. All forward-looking statements are inherently uncertain, based on current expectations and assumptions concerning future events or future performance of SafeCode Drug Technologies Corp., and its technologies. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release, as actual results may differ materially from those indicated. SafeCode Drug Technologies Corp. public filings may be viewed at http://www.sec.gov.
Contact:JERUSALEM, October 16, 2012 /PRNewswire/ --
SafeCode Drug Technologies Corp. (OTCBB: SAFC), a developer of a patent-pending voice recognition technology that reduces the risks of errors during of administration of prescription medications, announced today that the company has been granted eligibility status by the Depository Trust Company (DTC). The DTC provides banks, brokerage firms and other institutions with an efficient means of moving securities and settling trades electronically.
"SafeCode Drug Technologies has acquired the patent-pending voice recognition technology that can significantly reduce the risks of errors of administering the wrong medication," said Joel Klopfer, CEO of SafeCode Drug Technologies. "We are excited to being able in the future to bring this potentially life-saving technology to the market."
About SafeCode Drug Technologies
SafeCode Drug Technologies is the developer of a patent-pending voice recognition technology that provides an essential degree of security that can effectively prevent unauthorized administration of a prescription medication.
Forward-Looking Statements
This letter contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities Exchange Act of 1934 as amended. All forward-looking statements are inherently uncertain, based on current expectations and assumptions concerning future events or future performance of SafeCode Drug Technologies Corp., and its technologies. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release, as actual results may differ materially from those indicated. SafeCode Drug Technologies Corp. public filings may be viewed at http://www.sec.gov.
Contact:
Joel Klopfer
CEO
+97225021322
Joel.Klopfer1@gmail.com
SOURCE Safecode Drug Technologies Corp.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |